Charles & Colvard manufactures, markets, and distributes Charles & Colvard Created Moissanite? (which the company refers to as moissanite or moissanite jewels) and finished jewelry featuring its proprietary moissanite gemstone for sale in the worldwide jewelry market. The company sells loose moissanite jewels and finished jewelry through various operating segments: its Online Channels segment, which comprises its charlesandcolvard.com website, e-commerce outlets, including marketplaces, drop-ship customers, and other e-commerce customers; and its Traditional segment, which consists of domestic and international distributors and retail customers.

Molecular Templates is a clinical-stage company focused on the discovery and development of biologic therapeutic for cancer and other serious diseases. The company utilizes its proprietary biologic drug platform to design and generate engineered toxin bodies (ETBs). The company is developing ETBs for various targets, including CD20, CD38, HER2, PD-L1, CTLA-4, SLAMF-7, and CD45. CD20 is central to B cell malignancies and is clinically validated as a target for the treatment of lymphomas and autoimmune disease. CD38 has been validated as a clinical target in the treatment of various myeloma. PD-L1 is central to immune checkpoint pathways and is a target expressed in a variety of solid tumor cancers.

State Auto Financial is a property and casualty insurance holding company. Through its subsidiaries, the company is engaged in writing personal and business insurance. The company's reportable insurance segments are personal insurance and commercial insurance. In its personal insurance segment, the company writes standard insurance covering personal exposures to individuals. The primary coverages provided are personal auto, homeowners, and other personal. In its commercial insurance segment, the company writes standard insurance covering small to medium sized commercial exposures. The company provides coverages including commercial auto, small commercial package, farm and ranch, workers' compensation and other commercial.

Universal Display is engaged in the research, development and commercialization of organic light emitting diode (OLED) technologies and materials for use in displays and lighting applications. The company manufactures and sells its proprietary OLED materials to customers for evaluation and use in commercial OLED products. The company also enters into agreements with manufacturers of OLED display and lighting products under which the company grants them licenses to practice under the company's patents and to use the company's proprietary know-how. At the same time, the company works with these and other companies that are evaluating the company's OLED technologies and materials for possible use in commercial OLED display and lighting products.